{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["intratumoral injection", "local anticancer therapy", "melanoma", "nitric oxide", "nitric oxide releasing nanoparticles", "tumor penetration"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34162207", "DateCompleted": {"Year": "2021", "Month": "08", "Day": "02"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "06", "Day": "23"}], "Language": ["eng"], "ELocationID": ["10.1021/acsami.1c07407"], "Journal": {"ISSN": "1944-8252", "JournalIssue": {"Volume": "13", "Issue": "26", "PubDate": {"Year": "2021", "Month": "Jul", "Day": "07"}}, "Title": "ACS applied materials & interfaces", "ISOAbbreviation": "ACS Appl Mater Interfaces"}, "ArticleTitle": "Tumor-Penetrable Nitric Oxide-Releasing Nanoparticles Potentiate Local Antimelanoma Therapy.", "Pagination": {"StartPage": "30383", "EndPage": "30396", "MedlinePgn": "30383-30396"}, "Abstract": {"AbstractText": ["Although nitric oxide (NO) has been emerging as a novel local anticancer agent because of its potent cytotoxic effects and lack of off-target side effects, its clinical applications remain a challenge because of the short effective diffusion distance of NO that limits its anticancer activity. In this study, we synthesized albumin-coated poly(lactic-<i>co</i>-glycolic acid) (PLGA)-conjugated linear polyethylenimine diazeniumdiolate (LP/NO) nanoparticles (Alb-PLP/NO NPs) that possess tumor-penetrating and NO-releasing properties for an effective local treatment of melanoma. Sufficient NO-loading and prolonged NO-releasing characteristics of Alb-PLP/NO NPs were acquired through PLGA-conjugated LP/NO copolymer (PLP/NO) synthesis, followed by nanoparticle fabrication. In addition, tumor penetration ability was rendered by the electrostatic adsorption of the albumin on the surface of the nanoparticles. The Alb-PLP/NO NPs showed enhanced intracellular NO delivery efficiency and cytotoxicity to B16F10 murine melanoma cells. In B16F10-tumor-bearing mice, the Alb-PLP/NO NPs showed improved extracellular matrix penetration and spatial distribution in the tumor tissue after intratumoral injection, resulting in enhanced antitumor activity. Taken together, the results suggest that Alb-PLP/NO NPs represent a promising new modality for the local treatment of melanoma."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan, South Korea."}], "LastName": "Lee", "ForeName": "Juho", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan, South Korea."}], "LastName": "Hlaing", "ForeName": "Shwe Phyu", "Initials": "SP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan, South Korea."}], "LastName": "Hasan", "ForeName": "Nurhasni", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan, South Korea."}], "LastName": "Kwak", "ForeName": "Dongmin", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan, South Korea."}], "LastName": "Kim", "ForeName": "Hyunwoo", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}], "LastName": "Cao", "ForeName": "Jiafu", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan, South Korea."}], "LastName": "Yoon", "ForeName": "In-Soo", "Initials": "IS"}, {"Identifier": ["0000-0003-1414-6169"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan, South Korea."}], "LastName": "Yun", "ForeName": "Hwayoung", "Initials": "H"}, {"Identifier": ["0000-0002-4794-483X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan, South Korea."}], "LastName": "Jung", "ForeName": "Yunjin", "Initials": "Y"}, {"Identifier": ["0000-0001-5216-5518"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan, South Korea."}], "LastName": "Yoo", "ForeName": "Jin-Wook", "Initials": "JW"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "ACS Appl Mater Interfaces", "NlmUniqueID": "101504991", "ISSNLinking": "1944-8244"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Azo Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Nitric Oxide Donors"}, {"RegistryNumber": "1SIA8062RS", "NameOfSubstance": "Polylactic Acid-Polyglycolic Acid Copolymer"}, {"RegistryNumber": "27432CM55Q", "NameOfSubstance": "Serum Albumin, Bovine"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "9002-98-6", "NameOfSubstance": "Polyethyleneimine"}], "CommentsCorrectionsList": [{"RefSource": "ACS Appl Mater Interfaces. 2022 Jun 8;14(22):26314. doi: 10.1021/acsami.2c07564", "PMID": "35617644"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "therapeutic use", "toxicity"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["chemical synthesis", "therapeutic use", "toxicity"], "DescriptorName": "Azo Compounds"}, {"QualifierName": [], "DescriptorName": "Cattle"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Drug Liberation"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Melanoma"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["chemistry", "therapeutic use", "toxicity"], "DescriptorName": "Nanoparticles"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["chemical synthesis", "therapeutic use", "toxicity"], "DescriptorName": "Nitric Oxide Donors"}, {"QualifierName": ["analogs & derivatives", "toxicity"], "DescriptorName": "Polyethyleneimine"}, {"QualifierName": ["chemical synthesis", "chemistry", "toxicity"], "DescriptorName": "Polylactic Acid-Polyglycolic Acid Copolymer"}, {"QualifierName": ["chemistry", "toxicity"], "DescriptorName": "Serum Albumin, Bovine"}, {"QualifierName": [], "DescriptorName": "Mice"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2021", "Month": "6", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "24", "Hour": "5", "Minute": "25"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34162207", "10.1021/acsami.1c07407"]}}], "PubmedBookArticle": []}